Does VEMURAFENIB Cause Metastatic malignant melanoma? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Metastatic malignant melanoma have been filed in association with VEMURAFENIB (ZELBORAF). This represents 0.6% of all adverse event reports for VEMURAFENIB.
50
Reports of Metastatic malignant melanoma with VEMURAFENIB
0.6%
of all VEMURAFENIB reports
25
Deaths
7
Hospitalizations
How Dangerous Is Metastatic malignant melanoma From VEMURAFENIB?
Of the 50 reports, 25 (50.0%) resulted in death, 7 (14.0%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Metastatic malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEMURAFENIB. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does VEMURAFENIB Cause?
Rash (1,202)
Arthralgia (783)
Off label use (782)
Fatigue (773)
Diarrhoea (655)
Nausea (601)
Pyrexia (569)
Death (505)
Alopecia (445)
Decreased appetite (383)
What Other Drugs Cause Metastatic malignant melanoma?
DABRAFENIB (449)
TRAMETINIB DIMETHYL SULFOXIDE (267)
TRAMETINIB (173)
SILDENAFIL (116)
TALIMOGENE LAHERPAREPVEC (109)
NIVOLUMAB (87)
PREDNISONE (77)
PEMBROLIZUMAB (74)
TADALAFIL (71)
IPILIMUMAB (69)
Which VEMURAFENIB Alternatives Have Lower Metastatic malignant melanoma Risk?
VEMURAFENIB vs VENETOCLAX
VEMURAFENIB vs VENLAFAXINE
VEMURAFENIB vs VENTAVIS
VEMURAFENIB vs VENTOLIN
VEMURAFENIB vs VENTOLIN HFA